IP Verse

Culturing Of Human Embryonic Stem Cells At The Air-Liquid Interface For Differentiation Into Pancreatic Endocrine Cells

Patent No. EP2938724 (titled "Culturing Of Human Embryonic Stem Cells At The Air-Liquid Interface For Differentiation Into Pancreatic Endocrine Cells") was filed by Janssen Biotech on Dec 18, 2013. The application was issued on Oct 28, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ZWICKER SCHNAPPAUF & PARTNERJul 23, 2021GAENTZSCH
ZWICKER SCHNAPPAUF & PARTNERJul 23, 2021ZWICKER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2938724

JANSSEN BIOTECH
Application Number
EP13869259A
Filing Date
Dec 18, 2013
Status
Granted And Under Opposition
Sep 25, 2020
Publication Date
Oct 28, 2020
External Links
Slate, Register , Google Patents